The Association of the British Pharmaceutical Industry

Medicines are transforming our lives like never before. We want the UK to be the best place in the world to research, develop and use the medicines and vaccines of the future.

FIND OUT MORE

Building a thriving environment for medicine discovery

Improving access to new medicines and vaccines

Appropriate Prescribing, Ethics and Our Code

Representing our members
 

Clinical research in the UK: an opportunity for growth

Clinical research in the UK: an opportunity for growth

Clinical trials are an essential part of the research and development (R&D) of new medicines and vaccines, bringing benefits to patients, the NHS and the economy.

The ABPI's third annual report on clinical research in the UK looks at how we perform internationally, and how UK research was...

ABPI publishes third annual report on UK clinical research

The ABPI's report calls for lessons from COVID-19 to be used to revitalise the post-pandemic clinical research environment. 

Interactive charts from the report

The latest updated interactive charts are available, and also can be downloaded.

ABPI Patient Advisory Council

Patient leaders join new pharmaceutical industry advisory council

Eight leaders from across the patient and health charity sector have been named to the ABPI’s new Patient Advisory Council.

ABPI Patient Advisory Council

The ABPI Patient Advisory Council - made up of eight chief executives or members of the executive leadership team from across UK patient organisations, provides ABPI Board Members and Senior Executive Team with meaningful patient engagement to inform strategy, policy priorities and work-plans across...

NICE Methods and Process Review

What is the new severity modifier being proposed by NICE?

The way NICE assesses new medicines is changing. In the concluding stages of the Methods and Process Review, NICE is now consulting on changes to methods and processes for conducting health technology evaluations.

Our view of the latest NICE consultation

NICE is launching its final consultation on proposed changes to the way it develops recommendations across its health technology evaluation programmes.

NICE Methods and Process Review Consultations: Key Messages

The three consultations on NICE’s proposals for changing its methods and processes for health technology evaluation are the final step in a two year programme of work.

Attitudes towards pharmaceutical companies in the UK

ABPI-Ipsos MORI attitudes towards pharmaceutical companies in the UK

This study outlines some of the headlines and key insights from a year of research with the public, healthcare professionals and Members of Parliament to find out what they really think and feel about pharmaceutical companies in the UK. 

We’ve combined ongoing qualitative and quantitative research with in-depth analysis to bring you a comprehensive snapshot of the industry’s reputation.

New research reveals attitudes to pharmaceutical industry

Research published by Ipsos MORI and the ABPI provides new insight into perceptions of the pharmaceutical sector in the UK.

ABPI 2021 Code of Practice

Code of Practice for the Pharmaceutical Industry 2021

The pharmaceutical industry in the United Kingdom is committed to benefiting patients by operating in a professional, ethical and transparent manner to ensure the appropriate use of medicines and support the provision of high quality healthcare.

The Code covers the promotion of medicines for...

The ABPI Principles - at the heart of the new Code

The new ABPI Principles are:

• Benefitting patients,
• Acting with integrity,
• Promoting transparency
• Treating everyone with respect.

New 2020 Disclosure UK data published

The latest Disclosure UK data for 2020 has been published by the ABPI showing 7 in 10 healthcare professionals have agreed to be named.

Valuing Vaccines

#ValuingVaccines

Vaccines developed by the pharmaceutical industry are transforming the lives of millions of people, every day. Find out how.

Why vaccines matter

Vaccines developed by the pharmaceutical industry save lives, prevent diseases, benefit our economy and support the NHS.

How are vaccines researched and developed?

The UK has a longstanding reputation for vaccine development.

Responding to COVID-19

Coronavirus: Your questions answered

The COVID-19 pandemic is an unprecedented situation that is constantly changing. To help you understand how the pharmaceutical industry is responding, we answer your questions.

What impact will coronavirus have on the medicines supply chain?

Our members are working 24/7 to get medicines to patients during the coronavirus pandemic. 

What Government guidance and advice is available?

Bringing together the most up-to-date information from the UK Government.

What is the life sciences sector doing to help increase COVID-19 testing?

The Government has confirmed that COVID-19 testing capacity will increase. 

How are life sciences companies helping the NHS on the ground?

As part of the health community, the life sciences sector in the UK wants to play as big a role as possible in tackling COVD-19.

What are pharmaceutical companies doing to tackle COVID-19?

There are significant global efforts underway to diagnose, treat and prevent infections from the virus. Pharmaceutical companies are working globally to combat COVID-19.

Facts and Figures

Members

Online members portal

My ABPI members can log in for bespoke content and services

MORE ABOUT ABPI MEMBERSHIP

LOGIN

News

20 October 2021

ABPI response to COVID-19 antivirals announcement

The government has made a deal to secure 2 new antiviral COVID-19 treatments for this winter.

20 October 2021

UK manufacturing holds key to unlocking Government’s domestic and global ambitions

The success of the UK’s manufacturing sector will be central to the government’s ability to deliver on its national ambitions to level up the whole country, reach Net Zero by 2050 and become a global science superpower.

29 September 2021

ABPI publishes third annual report on UK clinical research

The ABPI's report calls for lessons from COVID-19 to be used to revitalise the post-pandemic clinical research environment. 

22 September 2021

ABPI response to national overprescribing review

The ABPI supports today’s report on overprescribing and looks forward to working with system partners to implement its recommendations.

All News

Publications

Manufacturing 5: Investing in advanced manufacturing is investing in levelling up

WTO Twelfth Ministerial Conference: A Critical Opportunity to Strengthen the Global Trade and Health Agenda

All Publications

Blog

30 September 2021

Invest and innovate to keep UK life sciences globally competitive

Richard Torbett outlines the case for investing in our sector ahead of the autumn's Comprehensive Spending Review.

25 August 2021

A new strategy for cancer in Northern Ireland

The Department of Health Northern Ireland has launched a consultation for a 10-year strategy to tackle cancer. 

All Blogs

Twitter

FOLLOW US